reteplase FDA Link

mutant form of tissue plasminogen activator used in treatment of myocardial infarct

Also Known As:

173-527-plasminogen activator (human tissue-type), 173- L- serine- 174- L- tyrosine- 175- L- glutamine- ; BM 06.022; BM 06022; BM-06.022; Rapilysin; Retavase

Pharmalogical Action Categories:

D005343 - Fibrinolytic Agents

Enzymes and Coenzymes: 1
- Enzymes: 152586
  - Hydrolases: 2166
    - Peptide Hydrolases: 23957
      - Serine Proteases: 3726
        Serine Endopeptidases: 11
        Tissue Plasminogen Activator: 10595
        reteplase: 215
      - Endopeptidases: 633
        Serine Endopeptidases: 11
        Tissue Plasminogen Activator: 10595
        reteplase: 215
Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Blood Proteins: 12459
    - Blood Coagulation Factors: 5376
      - Plasminogen Activators: 5174
        Tissue Plasminogen Activator: 10595
        reteplase: 215
  - Recombinant Proteins: 2754
    - reteplase: 215
Biological Factors: 2472
- Blood Coagulation Factors: 5376
  - Tissue Plasminogen Activator: 10595
    - reteplase: 215

reteplase Products